Medical Devices
Medical devices, instruments, and equipment subject to safety, performance, and chemical-content regulations, including restrictions on hazardous substances in materials and components.
Foresight tracks Medical Devices developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Current activity
Intensifying
68% above the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
10 April 2026, 10:28
Latest Medical Devices alerts
The most recent regulatory and guidance signals tracked by Foresight
US FDA Issues Edition 2 Guidance On Pyrogen And Endotoxins Testing
In March 2026 the US FDA published Edition 2 of its Q&A guidance on pyrogen and endotoxins testing, updating expectations for sampling, method selection, and acceptance criteria across drugs, biologics, veterinary products, and medical devices.[^1^](https://www.fda.gov/media/83477/download) Manufacturers and contract labs should review endotoxin/pyrogen control strategies, pooling practices, and reliance on rabbit pyrogen tests to align with FDA’s risk‑based recommendations and its openness to validated alternative methods.
United StatesEU Commission Updates MDR Harmonised Standards for Sterilizers and Hearing Aids
The European Commission has updated the list of harmonised standards under the Medical Devices Regulation (MDR), introducing new technical specifications for small steam sterilizers, steam boilers, and hearing aids as of April 2026. Manufacturers should adopt these updated standards to maintain the presumption of conformity with MDR essential requirements and ensure continued market access for these specific device categories.
European UnionUS FDA Requires ICH E2B(R3) Format for Postmarketing ICSR Submissions From 1 October 2026
The US FDA will mandate the ICH E2B(R3) data standard for all postmarketing individual case safety reports (ICSRs) submitted via ESG NextGen starting October 1, 2026. Manufacturers must upgrade pharmacovigilance systems and data workflows now to ensure seamless transition and avoid submission rejections when the legacy E2B(R2) standard is retired.
United StatesSouth Korea MFDS Consults on Amendment to Enforcement Rule of the Medical Devices Act (Public Notice No. 2026-172)
South Korea's MFDS has proposed amendments to the Medical Devices Act Enforcement Rule to formalize GMP conformity assessment procedures and technical document review body renewals. Manufacturers should prepare for more structured quality management audits and review potential post-marketing study exemptions for orphan devices to ensure continued market access.
South KoreaUK and US Agree Arrangement on Pharmaceutical Trade, Pricing and Supply Chains
The UK and US have finalized a bilateral pharmaceutical arrangement, effective April 2026, to significantly increase UK medicine spending and provide US tariff protection for UK exports. This deal improves commercial predictability through higher reimbursement ceilings and rebate caps while signaling deeper regulatory alignment on medical device approvals and supply chain security.
United KingdomUnited StatesEU Commission Amends Harmonised Standards for Sterilisers and Hearing Aids Under Decision 2021/1182
The European Commission has updated the list of harmonised standards for medical devices, specifically targeting sterilisers and electroacoustic hearing aids. Manufacturers must prepare to align technical documentation with these revised standards to maintain the presumption of conformity under the Medical Devices Regulation (EU) 2017/745.
European UnionEuropean Commission DG SANTE Publishes Article 10a Decision Tree on Supply Interruption Notifications for Medical Devices
The European Commission has released a decision tree to clarify mandatory supply interruption notification requirements for medical device and IVD manufacturers under Regulation (EU) 2024/1860. This guidance provides a standardized framework for assessing patient safety risks and alternative availability, helping firms ensure compliance with reporting obligations during supply disruptions.
European UnionEU Commission Updates Q&A on Article 10a Medical Device Supply Interruption Notifications (Rev.2)
The European Commission has updated guidance on mandatory supply interruption notifications for medical devices and IVDs, clarifying the "serious harm" assessment criteria for manufacturers. Companies must integrate these standardized reporting forms and decision trees into their supply chain risk management to ensure compliance with the six-month advance notification requirement.
European UnionEU Parliament SANT Committee To Hear Proposal to Amend MDR and IVDR
The European Parliament's SANT Committee will review the Commission's proposal to simplify the MDR and IVDR frameworks on April 14, 2026. This legislative push aims to reduce administrative burdens and improve certification predictability, signaling potential relief for medical device manufacturers facing compliance bottlenecks.
European UnionNetherlands VWS Minister Confirms Structural Funding and Embedding of Pandemic Preparedness Programme
The Dutch government has committed €177 million annually to structurally embed pandemic preparedness into national health policy, focusing on surveillance, acute-care coordination, and medical countermeasure resilience. For life sciences and medical device sectors, this signals long-term investment in strategic stockpiling, supply chain resilience, and scalable production capacity for vaccines and diagnostics.
NetherlandsJapan METI and MHLW Establish Taskforce to Secure Pharmaceuticals, Medical Devices and Medical Supplies Affected by Middle East Situation
Japan has established a joint ministerial taskforce to address supply chain vulnerabilities for pharmaceuticals and medical devices linked to geopolitical instability in the Middle East. Businesses should anticipate increased government scrutiny of supply resilience and potential future measures to ensure the stable availability of critical medical supplies.
JapanUK Government Publishes Sector-Specific Guidance on UKCA and CE Product Marking
The UK government has issued consolidated guidance confirming the continued recognition of CE marking alongside UKCA for most product sectors in Great Britain. This provides regulatory stability for manufacturers, allowing for flexible market access while highlighting specific transition timelines for medical devices and construction products.
United KingdomEuropean UnionEU Commission Adopts Implementing Decision (EU) 2026/193 Updating Harmonised Standards For Medical Devices
The EU Commission updated the list of harmonised standards for medical devices under the MDR in January 2026, covering critical areas like sterilization and biological evaluation. Manufacturers must align technical documentation and conformity assessments with these revised standards to maintain market access and ensure regulatory compliance.
European UnionEuropean Economic AreaUK DHSC Consults On Justifying Non-Medical DEXA Scans for Sports and Wellness Use
The UK is consulting on permitting non-medical DEXA scans for sports and wellness purposes under ionising radiation regulations through June 2026. If approved, commercial providers must implement clinical-grade safety protocols, including equipment maintenance and dose optimization, to manage radiation risks for consumers.
United KingdomSouth Korea MFDS Consults On Draft Partial Amendment to Medical Device Approval, Notification and Examination Regulation (Notice No. 2026-167)
South Korea's MFDS proposed amendments to medical device regulations on March 30, 2026, to streamline approval processes and transition periods. The changes facilitate market access by expanding the use of real-world evidence and reducing administrative burdens for foreign-language documentation and product modifications.
South KoreaBrazil ANVISA Suspends Commercialisation, Distribution and Import of 30 In Vitro Diagnostic Devices From Biomolecular Technology
ANVISA has immediately suspended the sale and import of 30 IVD medical devices from Biomolecular Technology due to Good Manufacturing Practice (GMP) violations. Companies must halt distribution of affected lots and review supply chains for blood-glucose monitoring products to ensure compliance and mitigate operational disruption.
BrazilBrazil (ANVISA) Prohibits Irregular Dermatological Medicines and Esthetic Products Sold Online
ANVISA has prohibited the sale and use of irregular dermatological medicines and unregistered aesthetic medical devices marketed through online platforms in Brazil. This enforcement action underscores heightened regulatory scrutiny of e-commerce supply chains and the critical necessity for valid sanitary registrations for all healthcare and aesthetic products.
BrazilEU Proposes Major Overhaul of MDR/IVDR to Cut Burdens and Protect Device Availability
The European Commission has proposed a major overhaul of the MDR and IVDR frameworks to simplify compliance and prevent supply shortages, with adoption expected by mid-2027. This shift toward open-ended certification and risk-based surveillance offers significant operational relief for manufacturers but requires careful navigation of emerging digital and cybersecurity reporting obligations.
European UnionUnited KingdomAnvisa Announces Brazil–Paraguay Sanitary Surveillance Cooperation And Global Dengue Technologies Coalition Call
Brazil and Paraguay have formalized a cooperation agreement to harmonize sanitary surveillance and intensify enforcement against counterfeit medicines and health products. This signals a shift toward tighter cross-border regulatory alignment in the Mercosur region, increasing scrutiny on product integrity and supply chain security for life sciences companies.
Brazil
ParaguayEuropean Parliament Draft Report on Implementation of Europe’s Beating Cancer Plan
The European Parliament's SANT Committee has issued a draft report demanding stricter tobacco controls, mandatory alcohol health warnings, and faster AI medical device approvals under Europe’s Beating Cancer Plan. This signals strong political pressure for upcoming revisions to tobacco, food, and medical device regulations, emphasizing mandatory labelling and streamlined market access for digital health innovations.
European UnionRelated topics
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Medical Devices alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Book a demoFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
